WUXIF (Wuxi AppTec Co) Beneish M-Score: -2.46 (As of Jun. 28, 2026)


WUXIF Wuxi AppTec Co Ltd WUXIF
84 GF Score
Price $15.63
GF Value $11.26
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Wuxi AppTec Co Beneish M-Score?

Wuxi AppTec Co WUXIF 84 Beneish M-Score is -2.46 as of Jun. 28, 2026. GuruFocus rates WUXIF with a GF Score™ of 84/100 and a GF Value™ of $11.26 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Wuxi AppTec Co ranks worse than 63.92% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.46 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Wuxi AppTec Co's Beneish M-Score or its related term are showing as below:

WUXIF' s Beneish M-Score Range Over the Past 10 Years
Min: -2.81   Med: -2.46   Max: 0.81
Current: -2.46

During the past 12 years, the highest Beneish M-Score of Wuxi AppTec Co was 0.81. The lowest was -2.81. And the median was -2.46.


Wuxi AppTec Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Wuxi AppTec Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wuxi AppTec Co Beneish M-Score Chart

Wuxi AppTec Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.34 -2.22 -2.53 -2.76 -2.54

Wuxi AppTec Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.68 -2.74 -2.65 -2.54 -2.46

WUXIF vs TMO, DHR, IDXX: Beneish M-Score Comparison

For the Diagnostics & Research subindustry, Wuxi AppTec Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuxi AppTec Co Beneish M-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's Beneish M-Score falls into.


WUXIF
84GF Score
Wuxi AppTec Co Ltd WUXIF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wuxi AppTec Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Wuxi AppTec Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8523+0.528 * 0.8559+0.404 * 0.7786+0.892 * 1.2057+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8881+4.679 * 0.023162-0.327 * 0.8262
=-2.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $1,245 Mil.
Revenue was 1804.352 + 1788.881 + 1692.628 + 1552.098 = $6,838 Mil.
Gross Profit was 909.44 + 899.607 + 852.595 + 719.332 = $3,381 Mil.
Total Current Assets was $9,456 Mil.
Total Assets was $15,585 Mil.
Property, Plant and Equipment(Net PPE) was $3,911 Mil.
Depreciation, Depletion and Amortization(DDA) was $0 Mil.
Selling, General, & Admin. Expense(SGA) was $152 Mil.
Total Current Liabilities was $2,763 Mil.
Long-Term Debt & Capital Lease Obligation was $325 Mil.
Net Income was 674.906 + 1004.525 + 493.385 + 680.87 = $2,854 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0 Mil.
Cash Flow from Operations was 521.729 + 822.116 + 558.974 + 589.877 = $2,493 Mil.
Total Receivables was $1,212 Mil.
Revenue was 1331.797 + 1584.934 + 1478.389 + 1276.274 = $5,671 Mil.
Gross Profit was 562.822 + 688.831 + 632.386 + 516.001 = $2,400 Mil.
Total Current Assets was $5,974 Mil.
Total Assets was $11,658 Mil.
Property, Plant and Equipment(Net PPE) was $3,553 Mil.
Depreciation, Depletion and Amortization(DDA) was $0 Mil.
Selling, General, & Admin. Expense(SGA) was $142 Mil.
Total Current Liabilities was $2,604 Mil.
Long-Term Debt & Capital Lease Obligation was $192 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1245.237 / 6837.959) / (1211.744 / 5671.394)
=0.182107 / 0.213659
=0.8523

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2400.04 / 5671.394) / (3380.974 / 6837.959)
=0.423183 / 0.494442
=0.8559

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (9455.653 + 3911.276) / 15585.16) / (1 - (5974.103 + 3552.701) / 11657.965)
=0.14233 / 0.182807
=0.7786

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6837.959 / 5671.394
=1.2057

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 3552.701)) / (0 / (0 + 3911.276))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(151.805 / 6837.959) / (141.765 / 5671.394)
=0.0222 / 0.024996
=0.8881

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((324.589 + 2762.799) / 15585.16) / ((191.619 + 2603.535) / 11657.965)
=0.198098 / 0.239763
=0.8262

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2853.686 - 0 - 2492.696) / 15585.16
=0.023162

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Wuxi AppTec Co has a M-score of -2.41 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.46 mean?
Wuxi AppTec Co (WUXIF) has a Beneish M-Score of -2.46 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Wuxi AppTec Co and its competitors. According to the industry distribution chart, Wuxi AppTec Co ranks #124 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 63.9%.
Is Wuxi AppTec Co's Beneish M-Score too high?
Wuxi AppTec Co's current Beneish M-Score is -2.46. Based on the distribution chart, Wuxi AppTec Co ranks #124 out of 194 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Wuxi AppTec Co has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's Beneish M-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Wuxi AppTec Co ranks #124 out of 194 companies for Beneish M-Score. This places Wuxi AppTec Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Diagnostics & Research company?
A good Beneish M-Score depends on the Medical Diagnostics & Research industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Wuxi AppTec Co and its competitors. Wuxi AppTec Co's current Beneish M-Score is -2.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (WUXIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $11.26, compared to a current price of $15.63 — trading 38.8% above its estimated fair value. The current Beneish M-Score is -2.46. Wuxi AppTec Co's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Wuxi AppTec Co (WUXIF), the current Beneish M-Score is -2.46 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wuxi AppTec Co (WUXIF) Overvalued in 2026?

Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued. The current stock price of $15.63 is trading 38.8% above its estimated GF Value™ of $11.26. GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.

Key valuation signals for WUXIF:

  • Beneish M-Score: -2.46
  • GF Value™: $11.26 vs. price of $15.63 (38.8% above fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the WUXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Wuxi AppTec Co Business Description

Address 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
84GF Score

Get the complete analysis for WUXIF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.63
Price
$11.26
GF Value